EZZ Life Science Holdings Limited (ASX: EZZ) - Share Price
- Current share price for EZZ : $0.465
EZZ Life Science Holdings Limited (EZZ) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a genomic life sciences company with a mission to advance quality of life and human health by leveraging cutting-edge genomic research and innovative products to address health challenges.
EZZ General Information +
| ASX Code | EZZ |
| Website | http://ezzlife.com.au |
| Industry/Sector | Life Sciences Tools & Services |
| Market Cap ($M) | 21 |
| EZZ Share Price | $0.465 |
| Day High | $0.470 |
| Day Low | $0.465 |
| Last Close | $0.465 |
| EZZ Share Price Movement | - ( No change ) |
Prices as at 16:40, 17 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
EZZ Life Science Holdings Limited (EZZ) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 2¢ | 100% | 24 Nov 2025 | 23 Dec 2025 | - | - | - |
| Result | 2¢ | 100% | 16 May 2025 | 17 Jun 2025 | - | - | - |
| HFResult | 2¢ | 100% | 5 Nov 2024 | 9 Dec 2024 | - | - | - |
See all dividends from EZZ Life Science Holdings Limited (EZZ) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
EZZ Life Science Holdings Limited (EZZ) price-sensitive announcements
EZZ - Quarterly Activity and Cashflow Report
EZZ Life Science Holdings Limited reported their quarterly activities and cash flow status
EZZ Life Science Holdings Limited (EZZ)
31 Jul 2026 | 3:49 PM
31 Jul 2026 | 3:49 PM
EZZ - Quarterly Activity and Cashflow Report
EZZ Life Science Holdings Limited released its Quarterly Activity and Cashflow Report for
EZZ Life Science Holdings Limited (EZZ)
30 Apr 2026 | 4:54 PM
30 Apr 2026 | 4:54 PM
EZZ - Half Yearly Report and Accounts
EZZ Life Science Holdings Limited reported a gross profit of 18.2 million AUD for the half
EZZ Life Science Holdings Limited (EZZ)
27 Feb 2026 | 4:03 PM
27 Feb 2026 | 4:03 PM
EZZ - EZZ Appoints Aumake in $10m Exclusive Distributor Agreement
EZZ Life Science Holdings Limited has announced a four-year global distribution agreement
EZZ Life Science Holdings Limited (EZZ)
17 Feb 2026 | 9:38 AM
17 Feb 2026 | 9:38 AM
EZZ Life Science Holdings Limited (EZZ) Recent ASX Announcements
EZZ Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | $6.73 | $14.60 | -10.00% | 16.10 | 4.00 | 1.70% | 100.0% |
| 2024A | $6.96 | $16.20 | 90.20% | 4.30 | 1.50 | 2.20% | 100.0% |
| 2023A | $3.63 | $8.50 | 175.10% | 4.50 | 1.00 | 2.50% | 100.0% |
EZZ Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| EZZ Life Science Holdings Limited (EZZ) | $22M | -0.1002 | 0.0000 | 0.0000 | 3.1959 | 0.0000 | 0.0000 | 8.60% | 0.00% | 0.00% |
EZZ Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.20 | 3.20 | 0.78 | 0.00 |
| Market | 0.30 | 13.10 | 1.16 | 0.67 |
| Sector | 0.51 | 33.10 | 2.42 | 2.70 |
EZZ Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Mark (Qizhou) Qin | Chief Executive Officer, Executive Director | 1 Sep 2018 |
| Ms Christine Chen | Executive Director | 16 Jan 2026 |
| Mr Gary Liu | Non-Executive Chairman, Non-Executive Director | 22 Jan 2026 |
| Mr Ivan Oshry | Non-Executive Director | 27 Oct 2020 |
| Ms Lily (Hao) Huang | Non-Executive Director | 27 Oct 2020 |
| Ms Janice Hsu | Non-Executive Director | 16 Jan 2026 |
EZZ Life Science Holdings Limited (EZZ) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 11 Dec 2024 | QIN, Mark (Qizhou) | Buy | Indirect Shares | 90,830 | $2.710 | $246,149.300 |
| 10 Dec 2024 | QIN, Mark (Qizhou) | Issued | Related Securities | 30,000 | $0.180 | $5,400.000 |
| 10 Dec 2024 | QIN, Mark (Qizhou) | Issued | Direct Shares | 1,000,000 | $2.550 | $2,550,000.000 |
See all changes in directors' interest & trades for EZZ Life Science Holdings Limited (EZZ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
EZZ Management
| Name | Position |
|---|---|
| Anthony Guarna | Chief Financial Officer |
| Jay Richard Stephenson | Company Secretary |
EZZ Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EZZ Life Science Holdings Limited (EZZ). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 17,016,000 (36.07%) | Macquarie Holdings Pty Ltd |
| 11,344,000 (26.17%) | JNJ Mok Pty Ltd |
EZZ Calendar of Events
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 28 August 2026 | Report (Annual) |
| 28 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
